Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
11/01/2007 | CA2825758A1 Colonic drug delivery formulation |
11/01/2007 | CA2800389A1 Glp-1 compounds |
11/01/2007 | CA2652759A1 Nanoparticles for providing immune responses against infectious agents |
11/01/2007 | CA2650922A1 Pre-mixed, ready-to-use nicardipine compositions |
11/01/2007 | CA2649630A1 Lipoplex formulations for specific delivery to vascular endothelium |
11/01/2007 | CA2649538A1 Buffering agents for biopharmaceutical formulations |
11/01/2007 | CA2649528A1 Therapeutic agent for allergy containing liposome having oligosaccharide on its surface |
11/01/2007 | CA2649514A1 Licorice polyphenol preparation |
11/01/2007 | CA2648854A1 Fluid container and airless fluid dispensing system |
11/01/2007 | CA2648553A1 Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation |
11/01/2007 | CA2648360A1 Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties |
11/01/2007 | CA2647768A1 Ige directed dna vaccination |
10/31/2007 | EP1849798A1 Cell permeable peptide |
10/31/2007 | EP1849487A2 Film-forming compositions and methods |
10/31/2007 | EP1849482A1 Multimodally altered cells as a form for administering active substances and as diagnostic particles |
10/31/2007 | EP1849481A1 Composition for external use |
10/31/2007 | EP1849477A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by ADP-ribosylating exotoxin |
10/31/2007 | EP1849472A1 Composition for preparing carbon dioxide preparation for external use |
10/31/2007 | EP1848804A2 Anti-muci alpha beta antibodies |
10/31/2007 | EP1848463A2 Method of conjugating aminothiol containing molecules to vehicles |
10/31/2007 | EP1848462A2 Methods for treating cancer using an immunotoxin comprising an exotoxin a moiety having a furin cleavage site replaced with a cancer-associated protease site cleaved by mmp-2 or mmp-9 |
10/31/2007 | EP1848461A2 Conjugates of an epo moiety and a polymer |
10/31/2007 | EP1848460A2 Synthesis of homopolymers and block copolymers |
10/31/2007 | EP1848459A2 Process for the preparation of polymer conjugates |
10/31/2007 | EP1848458A1 Use of activated polymers for separation of protein and polypeptide multimers |
10/31/2007 | EP1848446A1 Use of iron(iii) complex compounds |
10/31/2007 | EP1848439A1 Oral immediate release formulation of a poorly watersoluble active substance |
10/31/2007 | EP1848419A2 Injectable preparations of diclofenic and its pharmaceutically acceptable salts |
10/31/2007 | EP1848410A1 Polymer particle delivery compositions and methods of use |
10/31/2007 | EP1848398A1 Stabilization of viral compositions |
10/31/2007 | EP1848397A1 Composition containing chitosan for sustained drug release |
10/31/2007 | EP1848278A2 Oral formulations for delivery of catecholic butanes including ndga compounds |
10/31/2007 | EP1771180B1 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase |
10/31/2007 | EP1503760A4 Camptothecin derivatives and polymeric conjugates thereof |
10/31/2007 | EP1469941B1 Microparticles and methods for their production |
10/31/2007 | EP1360168A4 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof |
10/31/2007 | EP1315777B1 Degradable polyacetal polymers |
10/31/2007 | EP1214054B1 Intranasal influenza virus vaccine |
10/31/2007 | EP1140198B1 Use of hyaluronan for the manufacture of a medicament for the enhancement of the efficacy of cytotoxic drugs |
10/31/2007 | EP1078079B1 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
10/31/2007 | EP1012320B1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
10/31/2007 | DE60125750T2 Pharmazeutische formulierung enthaltend trägerkügelchen mit aufgebrachter schicht aus valaciclovir A pharmaceutical formulation comprising carrier beads made with an applied layer valaciclovir |
10/31/2007 | CN101065350A Stable crystal modifications of DOTAP chloride |
10/31/2007 | CN101065151A Cysteine engineered antibodies and conjugates |
10/31/2007 | CN101065150A 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists |
10/31/2007 | CN101065149A Use of amino-oxy functional groups in the preparation of protein-polysaccharide conjugate vaccines |
10/31/2007 | CN101065148A Conjugated complement cascade inhibitors |
10/31/2007 | CN101065131A Antimicrobial agents |
10/31/2007 | CN101065128A Solid formulations of liquid biologically active agents |
10/31/2007 | CN101065120A 4-hydroxy tamoxifen gel formulations |
10/31/2007 | CN101065116A Poly (lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar |
10/31/2007 | CN101065111A Dye-free pharmaceutical suspensions comprising sorbitol as a non-reducing sweetener and at least one active agent |
10/31/2007 | CN101065109A Method of formation of shape-retentive aggregates of gel particles and their uses |
10/31/2007 | CN101065107A Aqueous dispersions of a mixture of only slightly water soluble or water insoluble active substances and a single-celled protein material |
10/31/2007 | CN101065106A Triple natural polymer viscoelastic composition |
10/31/2007 | CN101062957A Gellan gum without organic solvent and production technique thereof |
10/31/2007 | CN101062950A Polyethylene glycol modified thymus peptide 1 derivative |
10/31/2007 | CN101062419A Polymer conjugates of interferon beta-1a and uses |
10/31/2007 | CN101062418A Cyclodextrin inclusion compound of entecavir, the preparing method and the medicine combination including the same |
10/31/2007 | CN101062417A Method for preparing gene medication carrier by using chitosan modified liposome |
10/31/2007 | CN101062416A Glucan ferroferric oxide magnetic nano-material and the preparing method thereof and the application |
10/31/2007 | CN101062408A Oral insulin compound medicine preparation and its preparing method |
10/31/2007 | CN101062406A Reeombinnt human granulocyte colony stimulating factor microemulsion |
10/31/2007 | CN101062403A Process for preparing bone peptide injection |
10/31/2007 | CN101062398A Radix rehmanniae pill for warming kidney |
10/31/2007 | CN101062375A 吴茱萸丸 Evodia pill |
10/31/2007 | CN101062374A Method for preparing Chinese traditional combination capsule for treating cancer and the product thereof |
10/31/2007 | CN101062329A Chinese traditional medicine massaging ointment for losing weight and the preparing method thereof |
10/31/2007 | CN101062297A Branch of cinnamomum wilsonii pill for treating cervical vertebrae |
10/31/2007 | CN101062289A External application medicine combination for treating gout |
10/31/2007 | CN101062271A Radix scrophulariae pill treating hypertension |
10/31/2007 | CN101062231A Pill of medlar and rehmannia |
10/31/2007 | CN101062227A Cyperus tuber pill for activating blood circulation |
10/31/2007 | CN101062208A Milkwort pills for relieving uneasiness |
10/31/2007 | CN101062160A Draba pills for treating asthma |
10/31/2007 | CN101062140A Zhima pill for treating cough |
10/31/2007 | CN101062127A Soft capsule for treating gynecopathy |
10/31/2007 | CN101062111A Analgesic buccal pill |
10/31/2007 | CN101062101A Material formula of olive fruit buccal tablet and the preparing method thereof |
10/31/2007 | CN101062095A Total salvianolic acids liposomes and the preparing method thereof |
10/31/2007 | CN101062094A Total salvianolic acids long-cycle liposomes and the preparing method thereof |
10/31/2007 | CN101062078A Extract of stevia whole stevioside and stevia whole flavone and the preparing method thereof |
10/31/2007 | CN101062066A Compound isatis-root injection for animals and the preparing method thereof |
10/31/2007 | CN101062064A Suhe pellet for protecting heart |
10/31/2007 | CN101062056A Low concentration of peroxide for treating or preventing vaginal infection |
10/31/2007 | CN101062055A Slowly-released type nanometer silver antibacterial gel and the preparing method and the application thereof |
10/31/2007 | CN101062054A Medicine for curing wound |
10/31/2007 | CN101062053A Reduced toxicity cisplatin formulations and methods for using the same |
10/31/2007 | CN101062049A Medical combination of teniposide, the preparing method and the function thereof |
10/31/2007 | CN101062044A Medicine combination including high-concentration polydatin |
10/31/2007 | CN101062042A Compound vibramycin injection for animals and the preparing method thereof |
10/31/2007 | CN101062040A Stable type cucurbitacin liquid formula and the agent thereof |
10/31/2007 | CN101062035A Therapeutic combinations comprising amlodipin and atorvastatin |
10/31/2007 | CN101062028A Combination including taxanes, the preparing method and the use thereof |
10/31/2007 | CN101062025A Compound anget for reducing weight, fat, sugar, pressure and for preventing and treating osteoporosis |
10/31/2007 | CN101062021A Diarrhea treating medical composition |
10/31/2007 | CN101062018A Hydrochloride clindamycin palmitate soft capsule and the preparing method thereof |
10/31/2007 | CN101062016A Immune micro-liposomal used in the cancer developing, diagnosing and treating and the application thereof |
10/31/2007 | CN101062013A Hydrochloride doxycycline injection for animals and the preparing method |
10/31/2007 | CN101062011A Calcium dobesilate injection |